Intracameral 5-fluorouracil and viscous dispersive viscoelastic for diffuse epithelial downgrowth management in aphakia
Intracameral epithelial downgrowth is one of the most feared complications in cases of penetrating ocular trauma or recurrent ocular surgeries. Its progress can affect all the ocular structures, giving rise to corneal decompensation, retinal detachment, difficult-to-treat glaucoma or phthisis bulbi...
| Autores: | , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2020 |
| País: | España |
| Institución: | Universidad Católica de Valencia San Vicente Mártir |
| Repositorio: | RIUCV. Repositorio de la Universidad Católica de Valencia San Vicente Mártir |
| Idioma: | inglés |
| OAI Identifier: | oai:riucv.ucv.es:20.500.12466/4563 |
| Acceso en línea: | http://hdl.handle.net/20.500.12466/4563 |
| Access Level: | acceso abierto |
| Palabra clave: | 3201.09 Oftalmología 3213.09 Cirugía Ocular |
| Sumario: | Intracameral epithelial downgrowth is one of the most feared complications in cases of penetrating ocular trauma or recurrent ocular surgeries. Its progress can affect all the ocular structures, giving rise to corneal decompensation, retinal detachment, difficult-to-treat glaucoma or phthisis bulbi and many cases end in enucleation[1]. Fortunately, the incidence of this condition is very low, there being between 0.08% and 0.12% after cataract surgery and 0.25% after penetrating keratoplasty. Its infrequency means that scientific evidence is reduced to case series and the opinions of experts without there being a homogeneous criterion to guide the work of the doctor in charge. For these reasons, epithelial downgrowth is still a diagnostic and therapeutic challenge |
|---|